These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37795818)

  • 41. Organs-on-chips technologies - A guide from disease models to opportunities for drug development.
    Monteduro AG; Rizzato S; Caragnano G; Trapani A; Giannelli G; Maruccio G
    Biosens Bioelectron; 2023 Jul; 231():115271. PubMed ID: 37060819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An ultrathin membrane mediates tissue-specific morphogenesis and barrier function in a human kidney chip.
    Mou X; Shah J; Roye Y; Du C; Musah S
    Sci Adv; 2024 Jun; 10(23):eadn2689. PubMed ID: 38838141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioengineering tissue morphogenesis and function in human neural organoids.
    Fedorchak NJ; Iyer N; Ashton RS
    Semin Cell Dev Biol; 2021 Mar; 111():52-59. PubMed ID: 32540123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global Trends of Organoid and Organ-On-a-Chip in the Past Decade: A Bibliometric and Comparative Study.
    Wang Z; He X; Qiao H; Chen P
    Tissue Eng Part A; 2020 Jun; 26(11-12):656-671. PubMed ID: 31847719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3D human tissue models and microphysiological systems for HIV and related comorbidities.
    ;
    Trends Biotechnol; 2024 May; 42(5):526-543. PubMed ID: 38071144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomanufacturing of 3D Tissue Constructs in Microgravity and their Applications in Human Pathophysiological Studies.
    Ren Z; Harriot AD; Mair DB; Chung MK; Lee PHU; Kim DH
    Adv Healthc Mater; 2023 Sep; 12(23):e2300157. PubMed ID: 37483106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineering mechanobiology through organoids-on-chip: A strategy to boost therapeutics.
    Charelli LE; Ferreira JPD; Naveira-Cotta CP; Balbino TA
    J Tissue Eng Regen Med; 2021 Nov; 15(11):883-899. PubMed ID: 34339588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling.
    Li Z; Xiang S; Li EN; Fritch MR; Alexander PG; Lin H; Tuan RS
    Handb Exp Pharmacol; 2021; 265():235-268. PubMed ID: 33471201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Comprehensive Review of Organ-on-a-Chip Technology and Its Applications.
    Farhang Doost N; Srivastava SK
    Biosensors (Basel); 2024 May; 14(5):. PubMed ID: 38785699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver 'organ on a chip'.
    Beckwitt CH; Clark AM; Wheeler S; Taylor DL; Stolz DB; Griffith L; Wells A
    Exp Cell Res; 2018 Feb; 363(1):15-25. PubMed ID: 29291400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Cell Pre-Wrapping Seeding Technique for Hydrogel-Based Tubular Organ-On-A-Chip.
    Nie J; Lou S; Pollet AMAO; van Vegchel M; Bouten CVC; den Toonder JMJ
    Adv Sci (Weinh); 2024 Aug; 11(30):e2400970. PubMed ID: 38872259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3D organ-on-a-chip: The convergence of microphysiological systems and organoids.
    Baptista LS; Porrini C; Kronemberger GS; Kelly DJ; Perrault CM
    Front Cell Dev Biol; 2022; 10():1043117. PubMed ID: 36478741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioinspired Engineering of Organ-on-Chip Devices.
    Wang L; Li Z; Xu C; Qin J
    Adv Exp Med Biol; 2019; 1174():401-440. PubMed ID: 31713207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Organoids and organoids-on-a-chip as the new testing strategies for environmental toxicology-applications & advantages.
    Hu C; Yang S; Zhang T; Ge Y; Chen Z; Zhang J; Pu Y; Liang G
    Environ Int; 2024 Feb; 184():108415. PubMed ID: 38309193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concise review: can the intrinsic power of branching morphogenesis be used for engineering epithelial tissues and organs?
    Nigam SK
    Stem Cells Transl Med; 2013 Dec; 2(12):993-1000. PubMed ID: 24191267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs.
    Liu Y; Sakolish C; Chen Z; Phan DTT; Bender RHF; Hughes CCW; Rusyn I
    Toxicology; 2020 Dec; 445():152601. PubMed ID: 32980478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public-private partnerships.
    Livingston CA; Fabre KM; Tagle DA
    Comput Struct Biotechnol J; 2016; 14():207-210. PubMed ID: 27904714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineering Organ-on-a-Chip Systems for Vascular Diseases.
    Shakeri A; Wang Y; Zhao Y; Landau S; Perera K; Lee J; Radisic M
    Arterioscler Thromb Vasc Biol; 2023 Dec; 43(12):2241-2255. PubMed ID: 37823265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
    Wang YI; Carmona C; Hickman JJ; Shuler ML
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioethical implications of organ-on-a-chip on modernizing drug development.
    Thakar RG; Fenton KN
    Artif Organs; 2023 Oct; 47(10):1553-1558. PubMed ID: 37578206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.